US Patent 9434697 Pyrimidine FGFR4 inhibitors
Patent 9434697 was granted and assigned to Eisai on September, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+124 characters)
Article
Patent abstract
Provided herein are compounds of Formula I useful as FGFR4 inhibitors, as well as methods of use of the same.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Anand Selvaraj0
Dominic Reynolds0
John Wang0
Ming-Hong Hao0
Sudeep Prajapati0
Takashi Satoh0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09434697 Pyrimidine FGFR4 inhibitors US Patent 9434697 Pyrimidine FGFR4 inhibitors
Infobox
Patent Number
094346970
Patent Number
94346970
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
094346970
Date of Patent
September 6, 2016
0Patent Application Number
150006590
Date Filed
January 19, 2016
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 8 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09434697 Pyrimidine FGFR4 inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09434697
Date of patent
September 6, 2016
Patent application number
15000659
Date Filed
January 19, 2016
Patent primary examiner
Find more entities like US Patent 9434697 Pyrimidine FGFR4 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
